Helices

DNA Data Storage Alliance Publishes First White Paper, Launches Website

Retrieved on: 
Thursday, June 10, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210610005250/en/
    The white paper, which can be found on the newly launched DNA Data Storage Alliance website, www.dnastoragealliance.org , presents DNA data storage fundamentals in an accessible way for both technically curious readers and for IT business, computer science or electrical engineering readers interested in the benefits, a technical overview, and the cost of ownership of this potential new storage medium.
  • It discusses why DNA data storage is needed and expected to address the exponential growth of digital data.
  • The DNA Data Storage Alliance expects to release additional white papers detailing use cases and market opportunities and requirements.
  • i Gartner, Emerging Technologies: New Active/Accessible and Deep Archive Data Requirements DNA Data Storage, John Monroe, April 23, 2021
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005250/en/

Global DNA & RNA Banking Services Market (2021 to 2028) - Share, Size, Trends and Industry Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, June 4, 2021

The "DNA & RNA Banking Services Market Share, Size, Trends, Industry Analysis Report, By Service; By Specimen; By Application; By End-Use, By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "DNA & RNA Banking Services Market Share, Size, Trends, Industry Analysis Report, By Service; By Specimen; By Application; By End-Use, By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global DNA & RNA banking services market size is expected to reach USD 9.29 billion by 2028 according to a new study.
  • In 2020, the drug discovery market segment of DNA & RNA banking services held the largest share.
  • For instance, Oxford Vaccine Center collects both RNA and DNA samples to offer data insights related to infectious diseases, resulting in driving the market growth for the DNA & RNA banking services.

Available Now! Whitepaper: Advancing Drug Discovery Through DNA Encoded Library Technology!

Retrieved on: 
Friday, May 28, 2021

HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today.

Key Points: 
  • HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today.
  • As demonstrated above, DEL potentials in drug discovery and/or other areas are being gradually explored.
  • DEL screening methods and models are being developed to include covalent screening, protein degradation molecular screening, and cell model-based DEL screening.
  • To explore more about technologies and services about HitGens DNA encoded library, please contact [email protected] .

Celsion Corporation to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021

Retrieved on: 
Friday, May 7, 2021

The call will also be broadcast live on the internet at www.celsion.com .

Key Points: 
  • The call will also be broadcast live on the internet at www.celsion.com .
  • The call will be archived for replay on Friday, May 14, 2021 and will remain available until May 28, 2021.
  • Celsion also has two platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
  • Celsion assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.\n'

Exro to Commercialize System Solutions with Heinzmann Motor Integration

Retrieved on: 
Thursday, March 25, 2021

"We are thrilled to see the successful integration of our motors with the Coil Driver technology," said Peter Mrimche, Managing Director for Heinzmann.

Key Points: 
  • "We are thrilled to see the successful integration of our motors with the Coil Driver technology," said Peter Mrimche, Managing Director for Heinzmann.
  • "This will deliver a unique system solution for light mobility applications and we are looking forward to bringing this to market alongside Exro."
  • Exro is a clean technology company pioneering intelligent control solutions in power electronics to help solve the most challenging problems in electrification.
  • Exro's advanced motor control technology, the Coil Driver, expands the capabilities of powertrains by enabling two separate torque profiles within a given motor.

DNA Script Names Philippe Lyko as Chief Financial Officer

Retrieved on: 
Tuesday, March 23, 2021

SAN FRANCISCO and PARIS, March 23, 2021 /PRNewswire/ --DNA Script, a leader in revolutionizing DNA synthesis on demand to accelerate scientific breakthroughs, has appointed Philippe Lyko as its new Chief Financial Officer.

Key Points: 
  • SAN FRANCISCO and PARIS, March 23, 2021 /PRNewswire/ --DNA Script, a leader in revolutionizing DNA synthesis on demand to accelerate scientific breakthroughs, has appointed Philippe Lyko as its new Chief Financial Officer.
  • "Philippe will play a transformative role at DNA Script as we launch the commercialization of the SYNTAX platform and progress toward our goal of revolutionizing DNA synthesis on demand," said Thomas Ybert, co-founder and CEO of DNA Script.
  • Founded in 2014, DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science.
  • By putting DNA synthesis back in the lab, DNA Script is transforming life science research through innovative technology that gives researchers full control and unprecedented autonomy.

DNA Script Names Philippe Lyko as Chief Financial Officer

Retrieved on: 
Tuesday, March 23, 2021

SAN FRANCISCO and PARIS, March 23, 2021 /PRNewswire/ --DNA Script, a leader in revolutionizing DNA synthesis on demand to accelerate scientific breakthroughs, has appointed Philippe Lyko as its new Chief Financial Officer.

Key Points: 
  • SAN FRANCISCO and PARIS, March 23, 2021 /PRNewswire/ --DNA Script, a leader in revolutionizing DNA synthesis on demand to accelerate scientific breakthroughs, has appointed Philippe Lyko as its new Chief Financial Officer.
  • "Philippe will play a transformative role at DNA Script as we launch the commercialization of the SYNTAX platform and progress toward our goal of revolutionizing DNA synthesis on demand," said Thomas Ybert, co-founder and CEO of DNA Script.
  • Founded in 2014, DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science.
  • By putting DNA synthesis back in the lab, DNA Script is transforming life science research through innovative technology that gives researchers full control and unprecedented autonomy.

Inkcups Expands Helix® Product Line with New Machine That’s Twice as Productive: The Double Helix®

Retrieved on: 
Tuesday, February 9, 2021

DANVERS, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Global printing industry leader Inkcups announces the release of the newest addition to the Helix line of products: the Double Helix .

Key Points: 
  • DANVERS, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Global printing industry leader Inkcups announces the release of the newest addition to the Helix line of products: the Double Helix .
  • The Double Helix features two side-by-side print stations that are able to simultaneouslyprint the same artwork on two of the same vessels.
  • Fast and flexible just like the flagship Helix, the Double Helix can print full-color seamless graphics at around 6 to 8 parts per minute depending on artwork size.
  • We are really excited to launch the Double Helix to the drinkware and industrial markets, and expect that it will be a major success.

Exro Update on Coil Driver for Electric Cars with Potencia

Retrieved on: 
Wednesday, February 3, 2021

CALGARY,AB, Feb. 3, 2021 /PRNewswire/ -ExroTechnologies Inc. (TSXV:EXRO) (OTC: EXROF)(the "Company"or "Exro"),a leadingclean technology companywhich has developed a new class of power electronics for electric motors andbatteries,is pleased to announcean update on the Coil Driver for electric cars withPotenciaIndustrial, S.A. DE C.V. ("Potencia").

Key Points: 
  • CALGARY,AB, Feb. 3, 2021 /PRNewswire/ -ExroTechnologies Inc. (TSXV:EXRO) (OTC: EXROF)(the "Company"or "Exro"),a leadingclean technology companywhich has developed a new class of power electronics for electric motors andbatteries,is pleased to announcean update on the Coil Driver for electric cars withPotenciaIndustrial, S.A. DE C.V. ("Potencia").
  • The in-house testing of the Potencia motor integrated with the Exro 100 Volt Coil Driver is complete and is being packaged to ship this Friday.
  • "Despite the slight delay, we are delighted to get the Coil Driver over to Potencia now and can't wait to see the results from their performance tests", said Sue Ozdemir, Chief Executive Officer of Exro.
  • Exro has developed a new class of control technology that expands the capabilities of electric motors, generators, and batteries.

EncrypGen Offers Individuals A Safer Path To Scaling Up The DNA Data Marketplace

Retrieved on: 
Tuesday, February 2, 2021

New York, New York, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EncrypGen , the worlds first blockchain-mediated genomic DNA data marketplace, applauds CBS 60 Minutes for its segment, The Big Money Market for Your DNA, examining the global DNA data market and highlighting existing business models that may result in the exploitation of consumer DNA data.

Key Points: 
  • New York, New York, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EncrypGen , the worlds first blockchain-mediated genomic DNA data marketplace, applauds CBS 60 Minutes for its segment, The Big Money Market for Your DNA, examining the global DNA data market and highlighting existing business models that may result in the exploitation of consumer DNA data.
  • From its outset, the EncrypGen platform had been built around the principle that consumers should be able to benefit from the multiple commercial uses of their DNA data.
  • Dedicated to democratizing the global DNA data market, we believe an honest and open discourse is a launchpad to positive change.
  • EncrypGen is dedicated to democratizing the market for the safe and equitable exchange of DNA data between individuals and medical and scientific researchers.